business
NanoViricides to raise $2M in registered direct offering
Key takeaways
- Under the terms of the agreement, the company will sell just over 1.3 million common shares, or pre-funded warrants in lieu thereof, together with accompanying warrants to purchase an equal number of common shares.
- Each warrant carries an exercise price of $1.75 per share and will expire three years from the date of issuance.
- The financing comes as the company reported cash and cash equivalents of approximately $3.38 million as of March 31, 2026.
Nano Viricides to raise $2M in registered direct offering Proactive Fri, May 15, 2026 at 9:02 PM GMT+7 1 min read NNVC Nano Viricides (NYSE-A:NNVC) said it has entered into a securities purchase agreement with a single institutional investor for gross proceeds of approximately $2 million in a registered direct offering.
Under the terms of the agreement, the company will sell just over 1.3 million common shares, or pre-funded warrants in lieu thereof, together with accompanying warrants to purchase an equal number of common shares.
Each warrant carries an exercise price of $1.75 per share and will expire three years from the date of issuance.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop